NOT KNOWN FACTUAL STATEMENTS ABOUT AGO TUMOR

These success within the future randomized studies on hypofractionation have internationally led to various assessments and proceed to dominate a controversially led dialogue. In copyright and Great Britain, hypofractionated radiation therapy is valued as the ‘new regular’ and assessed as becoming of equal benefit to normofractionated radiation